Global Liquid Biopsy Market Growth 2023-2029

Global Liquid Biopsy Market Growth 2023-2029

Increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D are some of the key factors driving the growth of the market.

LPI (LP Information)' newest research report, the “Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Liquid Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy sales for 2023 through 2029. With Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Liquid Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy.

The global Liquid Biopsy market size is projected to grow from US$ 806 million in 2022 to US$ 2788.3 million in 2029; it is expected to grow at a CAGR of 2788.3 from 2023 to 2029.

The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Test Suite
Equipment
Service

Segmentation by application
Food Laboratory
The Hospital
Research Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liquid Biopsy market?

What factors are driving Liquid Biopsy market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liquid Biopsy market opportunities vary by end market size?

How does Liquid Biopsy break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.